DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Infollion Research Services Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·10 Oct 2026, 3:58 pm

Infollion Research Services

Infollion Research Services Limited has informed stock exchanges that it has obtained a Certificate of Compliance under SEBI's Depositories and Participants Regulations, 2018. This regulatory document confirms that the company has fulfilled all necessary requirements to operate as a Depository Participant (DP).

For investors, this news is a procedural update rather than a market-moving event. It signifies that Infollion has met the regulatory standards set by the Securities and Exchange Board of India (SEBI) to facilitate the holding and settlement of securities. This compliance is a prerequisite for any entity wishing to act as a DP, ensuring a structured and secure framework for transactions.

Investors should note that this filing is a routine administrative step. It does not directly impact the company's financial performance or stock price. However, it reinforces the company's adherence to regulatory norms. The focus for now should remain on the company's core business operations and financial results rather than this regulatory filing.